Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1961 2
1963 2
1965 1
1966 1
1968 2
1970 4
1971 6
1972 1
1973 1
1974 10
1975 2
1976 6
1977 10
1978 8
1979 7
1980 10
1981 11
1982 4
1983 15
1984 12
1985 17
1986 9
1987 22
1988 11
1989 29
1990 21
1991 21
1992 26
1993 21
1994 30
1995 27
1996 21
1997 27
1998 36
1999 29
2000 25
2001 37
2002 24
2003 28
2004 39
2005 29
2006 43
2007 30
2008 25
2009 48
2010 36
2011 53
2012 67
2013 73
2014 112
2015 137
2016 170
2017 162
2018 182
2019 156
2020 135
2021 107
2022 121
2023 135
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

2,286 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics and pharmacodynamics of clozapine.
Jann MW, Grimsley SR, Gray EC, Chang WH. Jann MW, et al. Among authors: gray ec. Clin Pharmacokinet. 1993 Feb;24(2):161-76. doi: 10.2165/00003088-199324020-00005. Clin Pharmacokinet. 1993. PMID: 8453823 Review.
These studies have revealed a wide interpatient variability in pharmacokinetic parameters that include: time to reach peak plasma concentrations 1.1 to 3.6h; elimination half-life 9.1 to 17.4h; clearance 8.7 to 53.3 L/h; and a volume of distribution of 1.6 to 7.3 L/ …
These studies have revealed a wide interpatient variability in pharmacokinetic parameters that include: time to reach peak plasma concentrat …
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaborators; Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C. Cholesterol Treatment Trialists' (CTT) Collaborators, et al. Among authors: gray a. Lancet. 2012 Aug 11;380(9841):581-90. doi: 10.1016/S0140-6736(12)60367-5. Epub 2012 May 17. Lancet. 2012. PMID: 22607822 Free PMC article.
METHODS: This meta-analysis included individual participant data from 22 trials of statin versus control (n=134,537; mean LDL cholesterol difference 1.08 mmol/L; median follow-up 4.8 years) and five trials of more versus less statin (n=39,612; difference 0.51 mmol/L …
METHODS: This meta-analysis included individual participant data from 22 trials of statin versus control (n=134,537; mean LDL cholesterol di …
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Among authors: gray s. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Van Hest P106 - Systematic review of cefepime induced neurotoxicity L. Payne, G. L. Fraser P107 - Unasyn causes QT prolongation during treatment of intensive care patients B. ...S. Sedoni, D. L. Lucchesi, E. C. Carella, A. L Luciani P165 - Importance o …
Van Hest P106 - Systematic review of cefepime induced neurotoxicity L. Payne, G. L. Fraser P107 - Unasyn causes QT prolongatio …
Mutant-Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug-Resistant Mutations.
Jang J, To C, De Clercq DJH, Park E, Ponthier CM, Shin BH, Mushajiang M, Nowak RP, Fischer ES, Eck MJ, Jänne PA, Gray NS. Jang J, et al. Among authors: gray ns. Angew Chem Int Ed Engl. 2020 Aug 17;59(34):14481-14489. doi: 10.1002/anie.202003500. Epub 2020 Jul 9. Angew Chem Int Ed Engl. 2020. PMID: 32510788 Free PMC article.
Here, we develop an allosteric EGFR degrader, DDC-01-163, which can selectively inhibit the proliferation of L858R/T790M (L/T) mutant Ba/F3 cells while leaving wildtype EGFR Ba/F3 cells unaffected. DDC-01-163 is also effective against osimertinib-resistant cells with L …
Here, we develop an allosteric EGFR degrader, DDC-01-163, which can selectively inhibit the proliferation of L858R/T790M (L/T) mutant …
The biology of Ixodes ricinus with emphasis on its ecology.
Kahl O, Gray JS. Kahl O, et al. Among authors: gray js. Ticks Tick Borne Dis. 2023 Mar;14(2):102114. doi: 10.1016/j.ttbdis.2022.102114. Epub 2022 Dec 26. Ticks Tick Borne Dis. 2023. PMID: 36603231 Free article. Review.
Prior to its identification as the vector of Lyme borreliosis spirochaetes in Europe in 1983, interest in Ixodes ricinus (L.) was moderate and mainly concerned the transmission of pathogens to farm animals and of tick-borne encephalitis virus to humans. ...
Prior to its identification as the vector of Lyme borreliosis spirochaetes in Europe in 1983, interest in Ixodes ricinus (L.) was mod …
Engineering PTEN-L for Cell-Mediated Delivery.
Lavictoire SJ, Gont A, Julian LM, Stanford WL, Vlasschaert C, Gray DA, Jomaa D, Lorimer IAJ. Lavictoire SJ, et al. Among authors: gray da. Mol Ther Methods Clin Dev. 2017 Nov 21;9:12-22. doi: 10.1016/j.omtm.2017.11.006. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2017. PMID: 29255742 Free PMC article.
Unlike PTEN, PTEN-L has a signal sequence and a tract of six arginine residues that allow PTEN-L to be secreted from cells and be taken up by neighboring cells. ...Neural stem cells derived from human fibroblasts could be modified to express this version of PTEN- …
Unlike PTEN, PTEN-L has a signal sequence and a tract of six arginine residues that allow PTEN-L to be secreted from cells and …
Anesthesia Provision in Disasters and Armed Conflicts.
Trelles Centurion M, Van Den Bergh R, Gray H. Trelles Centurion M, et al. Among authors: gray h. Curr Anesthesiol Rep. 2017;7(1):1-7. doi: 10.1007/s40140-017-0190-0. Epub 2017 Feb 16. Curr Anesthesiol Rep. 2017. PMID: 28303086 Free PMC article. Review.
Visible-to-mid-IR tunable frequency comb in nanophotonics.
Roy A, Ledezma L, Costa L, Gray R, Sekine R, Guo Q, Liu M, Briggs RM, Marandi A. Roy A, et al. Among authors: gray r. Nat Commun. 2023 Oct 17;14(1):6549. doi: 10.1038/s41467-023-42289-0. Nat Commun. 2023. PMID: 37848411 Free PMC article.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Diouf I, Malpas CB, Sharmin S, Roos I, Horakova D, Havrdova EK, Patti F, Shaygannejad V, Ozakbas S, Izquierdo G, Eichau S, Onofrj M, Lugaresi A, Alroughani R, Prat A, Girard M, Duquette P, Terzi M, Boz C, Grand'Maison F, Hamdy S, Sola P, Ferraro D, Grammond P, Turkoglu R, Buzzard K, Skibina O, Yamout B, Altintas A, Gerlach O, van Pesch V, Blanco Y, Maimone D, Lechner-Scott J, Bergamaschi R, Karabudak R, Iuliano G, McGuigan C, Cartechini E, Barnett M, Hughes S, Sa MJ, Solaro C, Kappos L, Ramo-Tello C, Cristiano E, Hodgkinson S, Spitaleri D, Soysal A, Petersen T, Slee M, Butler E, Granella F, de Gans K, McCombe P, Ampapa R, Van Wijmeersch B, van der Walt A, Butzkueven H, Prevost J, Sinnige LGF, Sanchez-Menoyo JL, Vucic S, Laureys G, Van Hijfte L, Khurana D, Macdonell R, Gouider R, Castillo-Triviño T, Gray O, Aguera-Morales E, Al-Asmi A, Shaw C, Deri N, Al-Harbi T, Fragoso Y, Csepany T, Perez Sempere A, Trevino-Frenk I, Schepel J, Moore F, Kalincik T. Diouf I, et al. Among authors: gray o. Eur J Neurol. 2023 Apr;30(4):1014-1024. doi: 10.1111/ene.15706. Epub 2023 Feb 16. Eur J Neurol. 2023. PMID: 36692895 Free PMC article.
2,286 results